According to Cboe's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.22128. At the end of 2023 the company had a P/S ratio of 3.74.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.74 | 11.28% |
2022 | 3.36 | -15.5% |
2021 | 3.98 | 35.54% |
2020 | 2.94 | -44.79% |
2019 | 5.32 | 34.85% |
2018 | 3.94 | -37.42% |
2017 | 6.30 | -32.32% |
2016 | 9.31 | 10.89% |
2015 | 8.40 | -2.86% |
2014 | 8.64 | 9.66% |
2013 | 7.88 | 57.06% |
2012 | 5.02 | -43.57% |
2011 | 8.89 | 14.64% |
2010 | 7.76 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() CME Group CME | 13.9 | 230.27% | ๐บ๐ธ USA |
![]() Intercontinental Exchange ICE | 6.66 | 57.68% | ๐บ๐ธ USA |
![]() Nasdaq NDAQ | 3.94 | -6.62% | ๐บ๐ธ USA |
![]() BGC Partners
BGCP | 0.9229 | -78.14% | ๐บ๐ธ USA |